Sample Answer
Should the UK Spend a Greater Share of Its Budget on the NHS?
Introduction
The National Health Service plays a central role in the UK economy and in the daily lives of its population. Since its establishment in 1948, the NHS has been funded primarily through general taxation and has provided healthcare free at the point of use. In recent years, rising demand, an ageing population, workforce shortages and post-pandemic pressures have raised concerns about whether current levels of public spending are sufficient to maintain service quality. According to NHS England, waiting lists have reached record levels, while real-terms funding growth has struggled to keep pace with demand. This policy report examines whether the UK should allocate a greater share of its public budget to the NHS, using key microeconomic concepts to analyse the problem and inform policy recommendations.
Healthcare is not a typical market. It is characterised by strong externalities, information asymmetries and equity concerns that justify government intervention. The NHS therefore provides a valuable case study for analysing the role of government in correcting market failures and promoting social welfare. This report applies microeconomic theory to assess whether increased NHS spending would improve efficiency and welfare, while also recognising the fiscal and economic constraints faced by policymakers.
Application of Relevant Microeconomic Concepts
The role of government in the economy is particularly prominent in healthcare due to market failures that would otherwise lead to inefficient and inequitable outcomes. One of the most significant market failures in healthcare arises from positive externalities. When individuals receive medical treatment, the benefits extend beyond the patient to society as a whole. For example, vaccinations reduce the spread of infectious diseases, lowering healthcare costs and productivity losses across the economy. Left to the private market, such services would be under-consumed, justifying public funding through the NHS.
Healthcare also exhibits characteristics of a public good, particularly in areas such as disease surveillance, public health campaigns and emergency preparedness. These services are non-excludable and non-rival to a large extent, meaning private markets would fail to supply them efficiently. Increased NHS funding can therefore be seen as a means of addressing under-provision in these areas.
Asymmetric information is another major microeconomic issue within healthcare markets. Patients typically lack the medical knowledge required to make fully informed decisions, while healthcare providers possess significantly more information. This imbalance can lead to supplier-induced demand or inappropriate treatment choices if healthcare were primarily market-driven. The NHS reduces the impact of asymmetric information by regulating care provision, standardising treatment pathways and prioritising clinical need over ability to pay.
Social insurance theory further supports public healthcare spending. Health risks are uncertain and unevenly distributed across individuals. Without government intervention, many individuals would either be unable to afford private insurance or face exclusion due to pre-existing conditions. The NHS pools risk across the population, ensuring access to healthcare regardless of income or health status. From a microeconomic perspective, this risk pooling improves welfare by reducing uncertainty and protecting individuals from catastrophic health costs.
Evaluation of Existing Policies and Policy Recommendations
Current NHS funding policy aims to balance fiscal discipline with rising healthcare demand. While spending has increased in nominal terms, real-terms growth has been relatively modest when adjusted for inflation, demographic change and technological costs. Existing policy has focused heavily on efficiency savings, productivity targets and short-term funding settlements. Although these measures aim to control public expenditure, they may generate unintended consequences such as staff burnout, reduced service quality and longer waiting times.
From a microeconomic standpoint, underfunding the NHS risks exacerbating market failures rather than correcting them. For example, long waiting lists may push individuals towards private healthcare, increasing inequality and reducing the effectiveness of risk pooling. Preventive care may also be deprioritised, leading to higher long-run costs as untreated conditions become more severe.
This report recommends that the UK should allocate a greater share of its public budget to the NHS, but with spending targeted strategically rather than uniformly increased. Investment should prioritise preventive care, primary healthcare and workforce development. Preventive interventions often have high marginal social benefits relative to their costs, particularly in reducing future demand for expensive hospital treatments. Expanding primary care capacity can also improve allocative efficiency by ensuring patients receive appropriate treatment earlier.
Increased funding should also address information asymmetries through investment in digital health records and patient education. Better information improves decision-making for both patients and providers, leading to more efficient resource allocation. Workforce investment is equally critical, as labour shortages reduce productive efficiency and limit the NHS’s ability to meet demand even when financial resources are available.
Importantly, increased NHS spending should be accompanied by accountability mechanisms to ensure value for money. This includes outcome-based evaluation and evidence-led resource allocation, rather than reliance on across-the-board budget increases.
